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INTRODUCTION 
Congenital mesoblastic nephroma (CMN) is the most com-
mon renal solid tumor of the newborn period (1). CMN occurs
in two forms: a typical or leiomyomatous benign type seen
almost exclusively in infants under the age of three months
and an atypical or cellular type usually seen in older children,
but also occurring in infants. The latter type is potentially
malignant and capable of recurrence and metastasis (2). Mixed
forms with a combination of the two patterns have also been
reported (3). CMN is associated with polyhydramnios in most
cases, and surgical excision is almost always curative (4-8).
Although CMN has a good prognosis, rare cases of CMN
that show oligohydramnios resulting from fetal renal failure
may be difficult to diagnose accurately and such patients have
a poor prognosis due to the destruction of homeostasis. We
report a case of a congenital mesoblastic nephroma that pre-
sented with oligohydramnios, which was detected by ultra-
sonography in the prenatal period. Early and accurate prena-
tal diagnosis of a renal tumor may improve the outcome of
affected pregnancies by allowing for prompt implementa-
tion of the best strategy for prenatal management and deliv-
ery (9). The differential diagnosis of mesoblastic nephroma
includes hydronephrosis, focal renal dysplasia, multicystic
dysplastic kidney, malignant nephroblastoma, Wilms’ tumor,
diffuse nephroblastomatosis, and infantile polycystic kidney
disease (4, 5, 10-12). Accurate prenatal ultrasonography can
give diagnostic information useful for the detection of CMN. 
CASE REPORT
A 28-yr old woman, gravida 2, para 1, was referred to our
hospital at 34 weeks of gestation for oligohydramnios and a
fetal abdominal mass detected by ultrasonography. An earli-
er delivery had been performed by cesarean section, due to
breech presentation. The results of routine pregnancy tests
(CBC, U/A, viral marker, Toxoplasma, and others) were non-
specific and the triple test indicated that the patient was not
at high risk. At 24 weeks of gestation, ultrasonographic find-
ings showed a fetal weight (650 g) appropriate for the men-
strual dates, no fetal abnormality, and adequate amniotic fluid.
After the checkup, the patient did not receive antenatal care
for two months. At 33 weeks of gestation, the patient returned
to the local clinic where a fetal abdominal mass and a low
level of amniotic fluid were noted. The fetus was suspected
the intrauterine growth restriction (1,440 g, below 10% of
33 weeks of gestation), and the patient was referred to our
hospital. On admission, her vital signs were as follows; tem-
perature 36.0℃, pulse rate 84/min, respiration rate 20/min,
and blood pressure 120/80 mmHg. Laboratory findings were
not remarkable. An indicated sonography (using Aloka SSD-
5000) was performed. The amniotic fluid index was almost
zero. A huge (8.1×5.0×7.7 cm), well-encapsulated, abdo-
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A Case of Fetal Congenital Mesoblastic Nephroma with Oligohydramnios
Although congenital renal tumors are rare, congenital mesoblastic nephroma (CMN)
is the most common renal tumor in early infancy. It is non-metastatic, well differen-
tiated, amenable to surgical removal, and carries a good prognosis. Polyhydram-
nios has been detected in most of the published cases of CMN. However, we
experienced a rare case of fetal CMN associated with oligohydramnios. A 28-yr old
woman at 34 weeks of gestation was referred to our hospital for oligohydramnios
and a fetal abdominal mass. An ultrasonography revealed a huge, well-encapsu-
lated mass arising from the right kidney. An emergency cesarean section was per-
formed due to fetal distress. After birth, despite intensive neonatal care, the baby
died because of renal failure, disseminated intravascular coagulopathy, pulmonary
edema, together with other problems
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minal mass was detected, which was composed of both solid
and multiple cystic components (Fig. 1). The tumor arose
from the right fetal kidney, while the left kidney and other
fetal organs were normal. Upon fetal heart rate monitoring,
repeated severe variable deceleration was noted, and an emer-
gency cesarean section was performed. A female neonate
weighing 1,750 g, with Apgar scores of 5 at 1 min and 9 at
5 min, was delivered. The pH value of umbilical arterial blood
was 7.319.
On admission to the neonatal intensive care unit, the vital
signs of the neonate were as follows; temperature 36.5℃, pulse
rate 138/min, respiration rate 62/min, and blood pressure
69/43 mmHg. On physical examination, the infant showed
a remarkable abdominal mass 8 cm in diameter in the right
side of the abdomen. The mass was almost occupying the ab-
dominal cavity. The infant also had clubbed feet. Ultrasono-
graphic examination (using GE Logiq 9) and computed tomo-
graphy scan of the abdomen revealed a well circumscribed,
heterogeneous, non-enhanced mass 7 cm in diameter, origi-
nating from the right kidney, which showed both necrotic
and cystic components. The left kidney was normal (Fig. 2,
3). Within 24 hr of birth, the infant developed anuria, severe
anemia, hypoglycemia, and hypoalbuminemia. Prothrombin
time and activated prothrombin time were both prolonged.
Despite intensive treatment, no urine was ever excreted and
both generalized and pulmonary edema developed. On the
second day, gastrointestinal hemorrhage and hypotension
developed. The infant was resuscitated and intubated. Due
to the simultaneous presence of several severe systemic con-
ditions, radical nephrectomy could not be performed. The
laboratory findings showed general deterioration. Renal fail-
ure developed and hyperkalemia, hypoglycemia, thrombocy-
topenia, anemia, and poor coagulation profiles (aPTT unde-
tectably prolonged) could not be corrected despite major ther-
apeutic interventions. (Table 1). The infant died at four days
of age, owing to respiratory failure and disseminated intravas-
cular coagulopathy.
Fig. 3. Contrast-enhanced CT of right renal tumor. The CT scan
shows a well circumscribed, heterogeneous, non-enhanced mass
with dimensions 7.5×5.0×7.4 cm, developed from the right kid-
ney, with both necrotic and cystic components (white arrow). The
left kidney was normal (black arrow).
Fig. 1. Prenatal ultrasound reveals a well-encapsulated abdomi-
nal mass with dimensions 8.1×5.0×7.7 cm.
Fig. 2. Postnatal ultrasound reveals a huge, well circumscribed,
echocomplex mass, possibly arising from the right kidney.Fetal Congenital Mesoblastic Nephroma 359
Autopsy was performed and revealed an encapsulated mass,
with dimensions 8.5×8.0×5.0 cm arising from the right
renal pelvis. Cystic hemorrhage was observed (Fig. 4). On
the side of the mass, a remnant of the kidney, with dimen-
sions 2.0×0.8×2.0 cm, was seen. On cross section, the mass
was yellow to pink in color, and lobulated. The left kidney
and both lungs were normal. Microscopically, the tumor was
classified as a cellular mesoblastic nephroma (Fig. 5). The
neonate’s karyotype was normal (46, XX). 
DISCUSSION
CMN is the most common renal tumor in infancy, account-
ing for 3-6% of all childhood renal masses and 50% of all
solid tumors in the neonatal period (13). Current opinion
favors the classification of mesoblastic nephroma as a distinct,
and usually benign neoplasm, arising from the renal paren-
chyma (14). There appears to be a higher incidence of preterm
labor and premature rupture of membranes in pregnancies
complicated by CMN, as a result of associated polyhydram-
nios (4, 15). However, the mechanism of polyhydramnios is
unclear (16). Postulated mechanisms include a decreased gas-
trointestinal uptake due to compression by the lesion and
increased renal perfusion resulting in increased urine produc-
tion. Another mechanism, hypercalcemia induced polyuria of
the fetus, has been reported secondary to the tumor secretion
of prostaglandin. Hypercalcemias have been reported to be
caused by the tumor secretion of prostaglandin. Hyperten-
sion may also occur and may be caused by entrapment of renal
parenchyma by invading fibrous strands at the edge of the
tumor with resultant renin hypersecretion (2). 
Pathologically, the tumor has two patterns. The classical
pattern of CMN is a moderate cellular proliferation of thick
interlacing bundles of spindle cells, with elongated nuclei,
which usually infiltrate into the renal and perirenal tissues.
Mitotic figures are present usually in the range of 0 to 1 per
10 high power fields (17). The other pattern, termed cellular
mesoblastic nephroma, is more common, and consists of den-
sely cellular proliferation of polygonal cells with mitotic fig-
ures in the range of 8 to 30 per 10 high power fields (17).
Cysts are common in this pattern.
Sonographically, mesoblastic nephroma may present as a
large (4 to 8 cm), unilateral renal mass with nodular densi-
ties, or as diffuse renal enlargement. These tumors are pre-
dominantly solid, but cystic areas are occasionally seen (18).
Unlike Wilms’ tumor, there is no well-defined capsule, most
likely due to hemorrhage with subsequent cystic degenera-
tion (19). Patients suffering from CMN may show abnormali-
ties in systems not closely associated with the tumor. Such
abnormalities may include neuroblastoma (20), central ner-
vous system defects (5, 20), genitourinary problems, gastroin-
testinal difficulties, and limb abnormalities (5). Radical resec-
tion of the tumor is the treatment of choice, which is usually
curative (15). However, a small percentage of patients with
these tumors experience local recurrence or distant metastasis
due to inadequate resection (21) or cellular or atypical CMN,
which is potentially a malignant tumor (3, 22). No familial
or exogenous factors have been correlated to CMN occurrence,
in contrast to the development of Wilms’ tumor, for exam-
ple, where a familial link has been noted. There is no known
predisposition to its occurrence in siblings born to the same
mother after the birth of an affected infant. The condition is
not associated with other karyotypic abnormalities (15). Cyto-
genetic abnormalities such as trisomy 11 occur sporadically
(23, 24). However, Fuchs et al. reported a case of CMN occur-
ring in two siblings within one family and suggested that a
second-trimester anomaly scan with targeted examination
of the kidneys is warranted in families with a child affected
by CMN (25). 
In our case, the pregnant patient presented with oligohy-
dramnios, and the neonate showed anuria, hypotension, hy-
perkalemia, abnormal coagulation profiles, disseminated
intravascular coagulopathy, and other pathologic findings.
An associated anomaly noted was clubbed feet. On autopsy,
Day of life 1 2 3 4
WBC (/ L) 152,700 24,800 16,000 14,300
Hemoglobin (g/dL) 6.3 7.6 9.6 9.0
Platelet (/ L) 119,000 58,000 32,000 17,000
K (mEq/L) 3.5 4.2 5.2 5.4
Ca (Total/Ionized) (mEq/L) 5.7/2.8
Albumin (g/dL) 0.8 1.8 2.4 2.7
Creatine (mg/dL) 0.8 1.3 2.4 2.9
Glucose (mg/dL) 165 29 34 46
PT (sec) Not 40.3 40.9 37.0
coagulable
aPTT (sec) Not Not Not Slight
coagulable coagulable coagulable coagulable
Urine output  0 0 0 0
(cc/kg/hr)
Table 1. The serial laboratory findings of the neonate
Fig. 4. Gross photograph shows the encapsulated mass with di-
mensions 8.5×8.0×5.0 cm arising from the right renal pelvis. the tumor was shown to be a cellular mesoblastic nephroma
with mitotic figures more than 8 per 10 high power fields.
Areas of coagulative necrosis and hemorrhage were also ob-
served.
According to the literature, polyhydramnios was observed
in almost 40% of the CMN cases (20), and acute fetal distress
occurred in 25% of fetuses with CMN (26). Even though it
is important to note the high incidence of polyhydramnios
(24), CMN can also be accompanied by oligohydramnios,
which heralds a poor prognosis. Careful, continuous obser-
vation of the fetus should be considered when a renal tumor
is diagnosed on routine prenatal ultrasound, and close ultra-
sound follow-up and maternal-fetal monitoring should be
performed to detect any fetal complications. 
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